Mercer Global Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Sell
5,931
-1,544
-21% -$73.1K ﹤0.01% 2666
2025
Q4
$336K Buy
7,475
+815
+12% +$37.7K ﹤0.01% 2143
2025
Q3
$298K Sell
6,660
-2,151
-24% -$103K ﹤0.01% 2093
2025
Q2
$423K Buy
8,811
+3,339
+61% +$145K ﹤0.01% 1650
2025
Q1
$220K Buy
5,472
+774
+16% +$32.6K ﹤0.01% 1911
2024
Q4
$215K Buy
4,698
+102
+2% +$4.57K ﹤0.01% 1940
2024
Q3
$212K Sell
4,596
-4,857
-51% -$221K ﹤0.01% 1778
2024
Q2
$400K Buy
9,453
+3,432
+57% +$151K ﹤0.01% 1425
2024
Q1
$267K Buy
+6,021
New +$274K ﹤0.01% 1635

Other funds holding QGEN

Mercer Global Advisors's QGEN Position: Q1 2026 in Review

Mercer Global Advisors reduced its Qiagen (QGEN) stake by 21% in Q1 2026, selling an estimated $73.1K and leaving 5,931 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

Mercer Global Advisors first reported a position in QGEN in Q1 2024 and has held it in 9 quarters since. The position peaked at $423K in Q2 2025. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Mercer Global Advisors held 5,931 shares of Qiagen worth $237K as of Q1 2026.
  • Mercer Global Advisors sold 1,544 Qiagen shares in Q1 2026, an estimated $73.1K.
  • Qiagen made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #2666 holding.
  • Mercer Global Advisors first reported a position in Qiagen in Q1 2024 and has held it in 9 quarters since.
  • Mercer Global Advisors's Qiagen position peaked at $423K in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.